Improving Access to Breast Cancer Screening and Treatment in Nigeria: The Triple Mobile Assessment and Patient Navigation Model

O

Obafemi Awolowo University

Status

Enrolling

Conditions

Breast Cancer

Treatments

Other: Clinical Breast Examination
Device: iBreast device
Diagnostic Test: Mammography
Diagnostic Test: Breast ultrasound

Study type

Interventional

Funder types

Other
Industry

Identifiers

NCT05321823
ERC/2020/10/11 (26/10/2020)
#60303257 (Other Grant/Funding Number)

Details and patient eligibility

About

The goal of this study is to establish a novel community-based breast cancer program to address delayed presentation and lack of access to diagnostic and treatment facilities in South-West Nigeria. It is aimed at evaluating the impact of a novel breast cancer early detection program using triple mobile assessment (innovative handheld iBreast Exam \[iBE\] device, mobile ultrasound, and mobile mammography) and patient navigation program in a Nigerian community.

Full description

This study aims to provide screening to asymptomatic women 40-70 years and to provide diagnostic evaluation to women 30-70 years presenting with breast symptoms in a community in South-West Nigeria. The project will use a cluster randomized design with 1 community serving as the intervention arm and another community serving as the control arm. Both communities will receive breast cancer awareness and education but only the intervention community will receive screening, mobile imaging and navigation. Screening with targeted clinical history, Clinical Breast Exam (CBE), and iBE will be performed by trained Community Health Nurses in the intervention community. Women with positive CBE or iBE findings will undergo breast imaging with mobile mammography and portable ultrasound, as well as biopsy when indicated by the Radiologist who visits the community once a month, and receive navigation by the nurses to the point of care. The control population will receive breast cancer awareness without an organized screening, imaging or navigation program. Women presenting to the Primary Health Care Centers in the control community will be referred to the Teaching Hospital as per current standard of care. Record of all breast cancer cases seen in the 2 communities during the study period will be obtained.

Enrollment

4,100 estimated patients

Sex

Female

Ages

30 to 70 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Asymptomatic women 40 - 70 years
  • Symptomatic women (with breast-related symptoms) 30 - 70 years

Exclusion criteria

  • Male subjects
  • Women living outside the study locations (Ife East and Ife North districts)

Trial design

Primary purpose

Screening

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

4,100 participants in 2 patient groups

Control
No Intervention group
Description:
Two districts in Ife East Local County with an estimated screening population of 4,500 will be randomly selected to serve as the control community. The control arm will not receive iBE screening and clinical breast examinations by the community health nurses and nor get navigated to have ultrasound, mammography, biopsy and referral for treatment to the tertiary hospital if indicated within their community. All women for screening and diagnostic workup in the control community will be directed to the tertiary hospital to receive breast care.
Intervention
Experimental group
Description:
Three districts in Ife North Local County with an estimated screening population (women 40-70 years) of 5,800 will be randomly selected to serve as the intervention community. Women in the intervention community will receive iBreast and clinical breast examinations by the community health nurses and get navigated to have ultrasound, mammography, biopsy and referral for treatment to the tertiary hospital if indicated within their community.
Treatment:
Diagnostic Test: Breast ultrasound
Diagnostic Test: Mammography
Device: iBreast device
Other: Clinical Breast Examination

Trial contacts and locations

1

Loading...

Central trial contact

Adeleye D Omisore, MBBS, M.Sc, FWACS, FMCR

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems